For research use only. Not for therapeutic Use.
L-778123 free base(Cat No.:I030393)is a selective small-molecule inhibitor of the 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) enzyme. This enzyme plays a key role in the conversion of inactive cortisone to active cortisol in peripheral tissues, influencing the regulation of glucose, fat, and protein metabolism. By inhibiting 11β-HSD1, L-778123 has potential therapeutic applications in treating conditions related to cortisol excess, such as obesity, type 2 diabetes, and metabolic syndrome. Preclinical studies have demonstrated its ability to reduce cortisol levels and improve metabolic outcomes, although further clinical trials are needed to assess its safety and efficacy.
Catalog Number | I030393 |
CAS Number | 183499-57-2 |
Synonyms | L-778123 free base; L-778123; L 778123; L778123; L-778,123; L 778,123; L778,123; |
Molecular Formula | C22H20ClN5O |
Purity | 98% |
Target | Farnesyl Transferase |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | 4-[[5-[[4-(3-chlorophenyl)-3-oxopiperazin-1-yl]methyl]imidazol-1-yl]methyl]benzonitrile |
InChI | InChI=1S/C22H20ClN5O/c23-19-2-1-3-20(10-19)28-9-8-26(15-22(28)29)14-21-12-25-16-27(21)13-18-6-4-17(11-24)5-7-18/h1-7,10,12,16H,8-9,13-15H2 |
InChIKey | JNUGFGAVPBYSHF-UHFFFAOYSA-N |
SMILES | C1CN(C(=O)CN1CC2=CN=CN2CC3=CC=C(C=C3)C#N)C4=CC(=CC=C4)Cl |
Reference | 1: Ghasemi S, Davaran S, Sharifi S, Asgari D, Abdollahi A, Shahbazi Mojarrad J. Comparison of Cytotoxic Activity of L778123 as a Farnesyltranferase Inhibitor and Doxorubicin against A549 and HT-29 Cell Lines. Adv Pharm Bull. 2013;3(1):73-7. doi: 10.5681/apb.2013.012. Epub 2013 Feb 7. PubMed PMID: 24312815; PubMed Central PMCID: PMC3846042. |